Abiopharma

🔍 Francois Cedric (Executive)

Company: Apellis Pharmaceuticals, Inc. (APLS)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Sold 175,037 shares of Common Stock at $28.19 per share (Direct)
  Date: 2025-08-27 | Code: S | equity_swap_involved: false | shares_owned_after: 357,909.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 49,963 shares of Common Stock at $28.39 per share (Direct)
  Date: 2025-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 307,946.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | shares_owned_after: 331,605.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) | shares_owned_after: 472,065.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: Indirect Owner (The Francois Grossi Trust) | shares_owned_after: 300,000.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: Indirect Owner (The Francois-DuBois Educational Trust) | shares_owned_after: 234,411.00 | Footnotes: F6

Footnotes:

• F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.78 - $28.49, inclusive. The reporting person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
• F2: The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
• F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.14 - $28.68, inclusive.
• F4: The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
• F5: The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
• F6: The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.